venetoclax plus low-dose cytarabine in untreated older aml patients
Published 4 years ago • 243 plays • Length 5:39Download video MP4
Download video MP3
Similar videos
-
3:22
phase i/ii study of milademetan plus low-dose cytarabine with or without venetoclax in r/r aml
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
1:32
is venetoclax in combination with low-dose cytarabine a safe regimen for the treatment of aml?
-
5:31
the role of venetoclax in older patients with aml
-
3:52
venetoclax & aml
-
3:33
targeting bcl-2 in older aml: novel venetoclax combinations
-
12:05
venetoclax combinations, safety and efficacy
-
4:52
apoptosis and venetoclax
-
5:52
the power of venetoclax
-
2:48
safety and efficacy of venetoclax plus ldac in treatment-naive aml patients aged ≥ 65 years
-
2:25
venetoclax for aml
-
1:18
venetoclax combination therapies in aml
-
1:55
first-line venetoclax plus hma vs intensive chemotherapy in older adults with idh-mutated aml
-
7:55
comparison of venetoclax-based versus non-venetoclax-based treatment regimens in aml
-
1:24
omniverse: safety and tolerability of oral azacitidine plus venetoclax in patients with aml
-
5:36
venetoclax and azacitidine in mds patients
-
1:50
the challenge of treating elderly patients with aml with venetoclax plus azacitidine
-
1:21
intensive therapy of older aml
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
2:45
imgn632 plus venetoclax and/or azacitidine for patients with cd123-positive aml
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml
-
2:11
cpx-351 plus venetoclax in patients with newly-diagnosed high-risk aml